Maxidrol

Dexamethasone, neomycin sulfate and polymyxin B sulfate, the active ingredients in Maxidrol, are a corticosteroid and antibiotic combination presented as an ophthalmic solution for ocular use. It treats bacterial and inflammatory eye conditions such as conjunctivitis and post‑operative inflammation in adults and children.

GNH USA supplies Maxidrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxidrol is indicated for ocular conditions where inflammation and bacterial infection coexist. - Bacterial conjunctivitis: reduces bacterial load and associated inflammation, promoting faster symptom relief. - Post‑operative ocular inflammation: controls swelling and pain after eye surgery, aiding recovery. - Allergic conjunctivitis: diminishes allergic inflammation and discomfort in the conjunctiva. - Other inflammatory ocular conditions: provides anti‑inflammatory and antibacterial effects for various eye disorders.

Common Side Effects: - Eye irritation or burning sensation upon instillation. - Transient blurred vision. - Mild ocular itching or redness. - Slight increase in intra‑ocular pressure.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling or difficulty breathing. - Corneal ulceration or secondary ocular infection. - Development of cataract with prolonged use. - Glaucoma or marked rise in intra‑ocular pressure. - Persistent visual disturbances.

Before using Maxidrol, consider the following precautions: - Pregnancy: consult a healthcare professional as safety has not been established. - Breastfeeding: discuss potential risks with a physician. - Contact lens wearers: avoid using the drops while lenses are in place. - Pre‑existing glaucoma or ocular hypertension: monitor intra‑ocular pressure regularly. - Concurrent systemic corticosteroid therapy: assess for additive systemic effects. - Store at room temperature: keep in the original container, protect from light and moisture.

Maxidrol may interact with other ophthalmic agents. Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic side effects. - Antiviral eye drops (e.g., ganciclovir): potential antagonism of anti‑inflammatory effect. - Other potent ophthalmic NSAIDs: heightened risk of corneal toxicity.

Moderate Interactions (Monitor Closely):\n- Anticholinergic eye drops: may affect pupil size and intra‑ocular pressure. - Ocular antihistamines: monitor for additive irritation. - Additional topical antibiotics: assess for overlapping toxicity.